{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:07:01Z","timestamp":1793311621546,"version":"4.5.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Medical Science and Technology Program of Henan Province","award":["no. SBGJ202103096"],"award-info":[{"award-number":["no. SBGJ202103096"]}]},{"name":"the Medical Science and Technology Program of Henan Province","award":["no. SBGJ202103096"],"award-info":[{"award-number":["no. SBGJ202103096"]}]},{"name":"the Medical Science and Technology Program of Henan Province","award":["no. SBGJ202103096"],"award-info":[{"award-number":["no. SBGJ202103096"]}]},{"name":"the Medical Science and Technology Program of Henan Province","award":["no. SBGJ202103096"],"award-info":[{"award-number":["no. SBGJ202103096"]}]},{"name":"the Medical Science and Technology Program of Henan Province","award":["no. SBGJ202103096"],"award-info":[{"award-number":["no. SBGJ202103096"]}]},{"name":"the Medical Science and Technology Program of Henan Province","award":["no. SBGJ202103096"],"award-info":[{"award-number":["no. SBGJ202103096"]}]},{"name":"the Medical Science and Technology Program of Henan Province","award":["no. SBGJ202103096"],"award-info":[{"award-number":["no. SBGJ202103096"]}]},{"name":"the Medical Science and Technology Program of Henan Province","award":["no. SBGJ202103096"],"award-info":[{"award-number":["no. SBGJ202103096"]}]},{"name":"the China Postdoctoral Science Function","award":["no. 2024M750782"],"award-info":[{"award-number":["no. 2024M750782"]}]},{"name":"the China Postdoctoral Science Function","award":["no. 2024M750782"],"award-info":[{"award-number":["no. 2024M750782"]}]},{"name":"the China Postdoctoral Science Function","award":["no. 2024M750782"],"award-info":[{"award-number":["no. 2024M750782"]}]},{"name":"the China Postdoctoral Science Function","award":["no. 2024M750782"],"award-info":[{"award-number":["no. 2024M750782"]}]},{"name":"the China Postdoctoral Science Function","award":["no. 2024M750782"],"award-info":[{"award-number":["no. 2024M750782"]}]},{"name":"the China Postdoctoral Science Function","award":["no. 2024M750782"],"award-info":[{"award-number":["no. 2024M750782"]}]},{"name":"the China Postdoctoral Science Function","award":["no. 2024M750782"],"award-info":[{"award-number":["no. 2024M750782"]}]},{"name":"the China Postdoctoral Science Function","award":["no. 2024M750782"],"award-info":[{"award-number":["no. 2024M750782"]}]},{"name":"the Program for Innovative Talents of Science and Technology in Henan Province","award":["no. 23HASTIT043"],"award-info":[{"award-number":["no. 23HASTIT043"]}]},{"name":"the Program for Innovative Talents of Science and Technology in Henan Province","award":["no. 23HASTIT043"],"award-info":[{"award-number":["no. 23HASTIT043"]}]},{"name":"the Program for Innovative Talents of Science and Technology in Henan Province","award":["no. 23HASTIT043"],"award-info":[{"award-number":["no. 23HASTIT043"]}]},{"name":"the Program for Innovative Talents of Science and Technology in Henan Province","award":["no. 23HASTIT043"],"award-info":[{"award-number":["no. 23HASTIT043"]}]},{"name":"the Program for Innovative Talents of Science and Technology in Henan Province","award":["no. 23HASTIT043"],"award-info":[{"award-number":["no. 23HASTIT043"]}]},{"name":"the Program for Innovative Talents of Science and Technology in Henan Province","award":["no. 23HASTIT043"],"award-info":[{"award-number":["no. 23HASTIT043"]}]},{"name":"the Program for Innovative Talents of Science and Technology in Henan Province","award":["no. 23HASTIT043"],"award-info":[{"award-number":["no. 23HASTIT043"]}]},{"name":"the Program for Innovative Talents of Science and Technology in Henan Province","award":["no. 23HASTIT043"],"award-info":[{"award-number":["no. 23HASTIT043"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-024-01983-5","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T05:38:48Z","timestamp":1737783528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The role of celastrol in inflammation and diseases"],"prefix":"10.1007","volume":"74","author":[{"given":"Han","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruidong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"issue":"7203","key":"1983_CR1","first-page":"427","volume":"454","author":"U Weiss","year":"2008","unstructured":"Weiss U. Inflamm Nat. 2008;454(7203):427.","journal-title":"Inflamm Nat"},{"issue":"10","key":"1983_CR2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/138620710793360329","volume":"13","author":"P Zhou","year":"2010","unstructured":"Zhou P. Traditional Chinese medicine. Comb Chem High Throughput Screen. 2010;13(10):836.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"8","key":"1983_CR3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/ajh.2010.87","volume":"23","author":"T Morita","year":"2010","unstructured":"Morita T. Celastrol: a new therapeutic potential of traditional Chinese medicine. Am J Hypertens. 2010;23(8):821.","journal-title":"Am J Hypertens"},{"issue":"1","key":"1983_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/antiox9010037","volume":"9","author":"MW Lin","year":"2019","unstructured":"Lin MW, et al. Celastrol inhibits dopaminergic neuronal death of parkinson\u2019s disease through activating mitophagy. Antioxid (Basel). 2019;9(1):37.","journal-title":"Antioxid (Basel)"},{"issue":"5","key":"1983_CR5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","volume":"161","author":"J Liu","year":"2015","unstructured":"Liu J, et al. Treatment of obesity with celastrol. Cell. 2015;161(5):999\u20131011.","journal-title":"Cell"},{"issue":"26","key":"1983_CR6","doi-asserted-by":"crossref","first-page":"22216","DOI":"10.1074\/jbc.M112.356816","volume":"287","author":"SM Nanjundaiah","year":"2012","unstructured":"Nanjundaiah SM, et al. Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk. J Biol Chem. 2012;287(26):22216\u201326.","journal-title":"J Biol Chem"},{"key":"1983_CR7","doi-asserted-by":"crossref","first-page":"115075","DOI":"10.1016\/j.taap.2020.115075","volume":"400","author":"S Saber","year":"2020","unstructured":"Saber S, et al. Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats. Toxicol Appl Pharmacol. 2020;400:115075.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1983_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/or.2021.8040","volume":"45","author":"D You","year":"2020","unstructured":"You D, et al. Celastrol attenuates the inflammatory response by inhibiting IL-1\u03b2 expression in triple\u2013negative breast cancer cells. Oncol Rep. 2021;45(6):89.","journal-title":"Oncol Rep"},{"issue":"7","key":"1983_CR9","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1080\/15548627.2022.2046437","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang W et al. Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease. Autophagy. 2022;18(7):1740\u20132.","journal-title":"Autophagy"},{"key":"1983_CR10","doi-asserted-by":"crossref","first-page":"673209","DOI":"10.3389\/fphar.2021.673209","volume":"12","author":"PR Wagh","year":"2021","unstructured":"Wagh PR, et al. Nanotechnology-based celastrol formulations and their therapeutic applications. Front Pharmacol. 2021;12:673209.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1983_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin A, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13\u201327.","journal-title":"N Engl J Med"},{"key":"1983_CR12","volume-title":"World health statistics 2024: monitoring health for the SDGs, sustainable development goals","author":"World Health O","year":"2024","unstructured":"World Health O. World health statistics 2024: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization. 2024."},{"issue":"9793","key":"1983_CR13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","volume":"378","author":"BA Swinburn","year":"2011","unstructured":"Swinburn BA, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804\u201314.","journal-title":"Lancet"},{"key":"1983_CR14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-319-48382-5_11","volume":"960","author":"E Yilmaz","year":"2017","unstructured":"Yilmaz E. Endoplasmic reticulum stress and obesity. Adv Exp Med Biol. 2017;960:261\u201376.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1983_CR15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41591-019-0358-x","volume":"25","author":"X Feng","year":"2019","unstructured":"Feng X, et al. IL1R1 is required for celastrol\u2019s leptin-sensitization and antiobesity effects. Nat Med. 2019;25(4):575\u201382.","journal-title":"Nat Med"},{"key":"1983_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2017.01.043","volume":"799","author":"MH Abu Bakar","year":"2017","unstructured":"Abu Bakar MH, et al. Celastrol attenuates mitochondrial dysfunction and inflammation in palmitate-mediated insulin resistance in C3A hepatocytes. Eur J Pharmacol. 2017;799:73\u201383.","journal-title":"Eur J Pharmacol"},{"key":"1983_CR17","doi-asserted-by":"crossref","first-page":"173371","DOI":"10.1016\/j.ejphar.2020.173371","volume":"883","author":"MH Abu Bakar","year":"2020","unstructured":"Abu Bakar MH, et al. Celastrol attenuates inflammatory responses in adipose tissues and improves skeletal muscle mitochondrial functions in high fat diet-induced obese rats via upregulation of AMPK\/SIRT1 signaling pathways. Eur J Pharmacol. 2020;883:173371.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"1983_CR18","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.18632\/aging.101302","volume":"9","author":"D Luo","year":"2017","unstructured":"Luo D, et al. Natural product celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2\/HO-1, MAP kinase and NF-kappaB pathways. Aging. 2017;9(10):2069\u201382.","journal-title":"Aging"},{"issue":"5","key":"1983_CR19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4093\/dmj.2019.0124","volume":"44","author":"W Hu","year":"2020","unstructured":"Hu W, et al. Effects of microbiota on the treatment of obesity with the natural product celastrol in rats. Diabetes Metab J. 2020;44(5):747\u201363.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"1983_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ptr.6800","volume":"35","author":"X Yang","year":"2021","unstructured":"Yang X, et al. Celastrol alleviates metabolic disturbance in high-fat diet-induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation. Phytother Res. 2021;35(1):297\u2013310.","journal-title":"Phytother Res"},{"issue":"5","key":"1983_CR21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.apsb.2020.12.008","volume":"11","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, et al. Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice. Acta Pharm Sin B. 2021;11(5):1200\u201312.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1983_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/biof.1793","volume":"48","author":"MH Abu Bakar","year":"2022","unstructured":"Abu Bakar MH, et al. Celastrol attenuates high-fructose diet-induced inflammation and insulin resistance via inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in rat adipose tissues. BioFactors. 2022;48(1):111\u201334.","journal-title":"BioFactors"},{"key":"1983_CR23","doi-asserted-by":"crossref","first-page":"e72182","DOI":"10.7554\/eLife.72182","volume":"11","author":"D Luo","year":"2022","unstructured":"Luo D, et al. Covalent inhibition of endoplasmic reticulum chaperone GRP78 disconnects the transduction of ER stress signals to inflammation and lipid accumulation in diet-induced obese mice. Elife. 2022;11:e72182.","journal-title":"Elife"},{"key":"1983_CR24","doi-asserted-by":"crossref","first-page":"1094584","DOI":"10.3389\/fphar.2023.1094584","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu C, et al. Celastrol directly binds with VAMP7 and RAB7 to inhibit autophagy and induce apoptosis in preadipocytes. Front Pharmacol. 2023;14:1094584.","journal-title":"Front Pharmacol"},{"key":"1983_CR25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2019.08.026","volume":"310","author":"J Zhao","year":"2019","unstructured":"Zhao J, et al. Celastrol-loaded PEG-PCL nanomicelles ameliorate inflammation, lipid accumulation, insulin resistance and gastrointestinal injury in diet-induced obese mice. J Control Release. 2019;310:188\u201397.","journal-title":"J Control Release"},{"issue":"4","key":"1983_CR26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1039\/D1BM01637G","volume":"10","author":"N Fan","year":"2022","unstructured":"Fan N, et al. Biodegradable celastrol-loaded albumin nanoparticles ameliorate inflammation and lipid accumulation in diet-induced obese mice. Biomater Sci. 2022;10(4):984\u201396.","journal-title":"Biomater Sci"},{"key":"1983_CR27","doi-asserted-by":"crossref","first-page":"124023","DOI":"10.1016\/j.ijbiomac.2023.124023","volume":"236","author":"J Xian","year":"2023","unstructured":"Xian J, et al. N-Trimethylated chitosan coating white adipose tissue vascular-targeting oral nano-system for the enhanced anti-obesity effects of celastrol. Int J Biol Macromol. 2023;236:124023.","journal-title":"Int J Biol Macromol"},{"key":"1983_CR28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molimm.2018.10.021","volume":"104","author":"X Zhan","year":"2018","unstructured":"Zhan X, et al. Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway. Mol Immunol. 2018;104:61\u20138.","journal-title":"Mol Immunol"},{"key":"1983_CR29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41420-019-0196-0","volume":"5","author":"Z Sun","year":"2019","unstructured":"Sun Z, et al. Celastrol attenuates ox-LDL-induced mesangial cell proliferation via suppressing NLRP3 inflammasome activation. Cell Death Discov. 2019;5:114.","journal-title":"Cell Death Discov"},{"issue":"9","key":"1983_CR30","doi-asserted-by":"crossref","first-page":"e3201","DOI":"10.1002\/jgm.3201","volume":"22","author":"L Ma","year":"2020","unstructured":"Ma L, et al. Celastrol mitigates high glucose-induced inflammation and apoptosis in rat H9c2 cardiomyocytes via miR-345-5p\/growth arrest-specific 6. J Gene Med. 2020;22(9):e3201.","journal-title":"J Gene Med"},{"issue":"5","key":"1983_CR31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/a-1010-5543","volume":"129","author":"M Ouyang","year":"2021","unstructured":"Ouyang M, et al. Enhanced inflammatory reaction and thrombosis in high-fat diet-fed ApoE-\/- mice are attenuated by Celastrol. Exp Clin Endocrinol Diabetes. 2021;129(5):339\u201348.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1983_CR32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2023.03.004","volume":"200","author":"J Bian","year":"2023","unstructured":"Bian J, et al. Celastrol confers ferroptosis resistance via AKT\/GSK3beta signaling in high-fat diet-induced cardiac injury. Free Radic Biol Med. 2023;200:36\u201346.","journal-title":"Free Radic Biol Med"},{"issue":"18","key":"1983_CR33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","volume":"322","author":"ED Harris Jr","year":"1990","unstructured":"Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990;322(18):1277\u201389.","journal-title":"N Engl J Med"},{"issue":"5 Suppl 31","key":"1983_CR34","first-page":"S20","volume":"21","author":"DL Scott","year":"2003","unstructured":"Scott DL, et al. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol. 2003;21(5 Suppl 31):S20\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"1983_CR35","doi-asserted-by":"crossref","first-page":"e68905","DOI":"10.1371\/journal.pone.0068905","volume":"8","author":"G Li","year":"2013","unstructured":"Li G, et al. Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4\/NF-kappaB-mediated matrix metalloproteinase-9 expression. PLoS ONE. 2013;8(7):e68905.","journal-title":"PLoS ONE"},{"issue":"4","key":"1983_CR36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.intimp.2012.08.016","volume":"14","author":"GQ Li","year":"2012","unstructured":"Li GQ, et al. Celastrol inhibits interleukin-17A-stimulated rheumatoid fibroblast-like synoviocyte migration and invasion through suppression of NF-kappaB-mediated matrix metalloproteinase-9 expression. Int Immunopharmacol. 2012;14(4):422\u201331.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1983_CR37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.intimp.2014.12.012","volume":"24","author":"K Gan","year":"2015","unstructured":"Gan K, et al. Celastrol attenuates bone erosion in collagen-induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7. Int Immunopharmacol. 2015;24(2):239\u201346.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1983_CR38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.clim.2015.01.011","volume":"157","author":"B Astry","year":"2015","unstructured":"Astry B, et al. Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ. Clin Immunol. 2015;157(2):228\u201338.","journal-title":"Clin Immunol"},{"issue":"2","key":"1983_CR39","doi-asserted-by":"crossref","first-page":"e000438","DOI":"10.1136\/rmdopen-2017-000438","volume":"3","author":"R Cascao","year":"2017","unstructured":"Cascao R, et al. Effect of celastrol on bone structure and mechanics in arthritic rats. RMD Open. 2017;3(2):e000438.","journal-title":"RMD Open"},{"issue":"12","key":"1983_CR40","doi-asserted-by":"crossref","first-page":"e0142448","DOI":"10.1371\/journal.pone.0142448","volume":"10","author":"R Cascao","year":"2015","unstructured":"Cascao R, et al. Decrease of CD68 synovial macrophages in celastrol treated arthritic rats. PLoS ONE. 2015;10(12):e0142448.","journal-title":"PLoS ONE"},{"issue":"9","key":"1983_CR41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/genes8090221","volume":"8","author":"R Fang","year":"2015","unstructured":"Fang Z, et al. High-throughput study of the effects of celastrol on activated fibroblast-like synoviocytes from patients with rheumatoid arthritis. Genes (Basel). 2017;8(9):221.","journal-title":"Genes (Basel)"},{"issue":"16","key":"1983_CR42","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1111\/bph.14718","volume":"176","author":"VKW Wong","year":"2019","unstructured":"Wong VKW, et al. Ca(2+) signalling plays a role in celastrol-mediated suppression of synovial fibroblasts of rheumatoid arthritis patients and experimental arthritis in rats. Br J Pharmacol. 2019;176(16):2922\u201344.","journal-title":"Br J Pharmacol"},{"key":"1983_CR43","doi-asserted-by":"crossref","first-page":"106527","DOI":"10.1016\/j.intimp.2020.106527","volume":"84","author":"Q Gao","year":"2020","unstructured":"Gao Q, et al. Celastrol attenuates collagen-induced arthritis via inhibiting oxidative stress in rats. Int Immunopharmacol. 2020;84:106527.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"1983_CR44","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1159\/000517185","volume":"182","author":"X Lu","year":"2021","unstructured":"Lu X, et al. Celastrol exerts cardioprotective effect in rheumatoid arthritis by inhibiting TLR2\/HMGB1 signaling pathway-mediated autophagy. Int Arch Allergy Immunol. 2021;182(12):1245\u201354.","journal-title":"Int Arch Allergy Immunol"},{"key":"1983_CR45","doi-asserted-by":"crossref","first-page":"107879","DOI":"10.1016\/j.intimp.2021.107879","volume":"98","author":"M Jing","year":"2021","unstructured":"Jing M, et al. Celastrol inhibits rheumatoid arthritis through the ROS-NF-\u03baB-NLRP3 inflammasome axis. Int Immunopharmacol. 2021;98:107879.","journal-title":"Int Immunopharmacol"},{"key":"1983_CR46","doi-asserted-by":"crossref","first-page":"109241","DOI":"10.1016\/j.intimp.2022.109241","volume":"112","author":"J Yang","year":"2022","unstructured":"Yang J, et al. Celastrol inhibits rheumatoid arthritis by inducing autophagy via inhibition of the PI3K\/AKT\/mTOR signaling pathway. Int Immunopharmacol. 2022;112:109241.","journal-title":"Int Immunopharmacol"},{"key":"1983_CR47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fmed.2020.00455","volume":"7","author":"R Cascao","year":"2020","unstructured":"Cascao R, et al. Celastrol efficacy by oral administration in the adjuvant-induced arthritis model. Front Med (Lausanne). 2020;7:455.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"1983_CR48","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1021\/acs.nanolett.0c03279","volume":"20","author":"L An","year":"2020","unstructured":"An L, et al. Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-kappaB and Notch1 pathways. Nano Lett. 2020;20(10):7728\u201336.","journal-title":"Nano Lett"},{"issue":"1","key":"1983_CR49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1208\/s12248-021-00636-3","volume":"24","author":"X Zhao","year":"2021","unstructured":"Zhao X, et al. Reactive oxygen species-responsive celastrol-loaded: bilirubin nanoparticles for the treatment of rheumatoid arthritis. AAPS J. 2021;24(1):14.","journal-title":"AAPS J"},{"issue":"1","key":"1983_CR50","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/10717544.2022.2032482","volume":"29","author":"C Yu","year":"2022","unstructured":"Yu C, et al. Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis. Drug Deliv. 2022;29(1):454\u201365.","journal-title":"Drug Deliv"},{"issue":"1","key":"1983_CR51","first-page":"100777","volume":"18","author":"Y Yang","year":"2023","unstructured":"Yang Y, et al. An intra-articular injectable phospholipids-based gel for the treatment of rheumatoid arthritis. Asian J Pharm Sci. 2023;18(1):100777.","journal-title":"Asian J Pharm Sci"},{"issue":"3","key":"1983_CR52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00167-011-1705-8","volume":"20","author":"H Madry","year":"2012","unstructured":"Madry H, et al. Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012;20(3):407\u201322.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"12","key":"1983_CR53","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.joca.2012.07.010","volume":"20","author":"PM van der Kraan","year":"2012","unstructured":"van der Kraan PM. Osteoarthritis year 2012 in review: biology. Osteoarthritis Cartilage. 2012;20(12):1447\u201350.","journal-title":"Osteoarthritis Cartilage"},{"issue":"8 Suppl","key":"1983_CR54","first-page":"S223","volume":"15","author":"RW Moskowitz","year":"2009","unstructured":"Moskowitz RW. The burden of osteoarthritis: clinical and quality-of-life issues. Am J Manag Care. 2009;15(8 Suppl):S223\u20139.","journal-title":"Am J Manag Care"},{"issue":"1\u20133","key":"1983_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.01.057","volume":"708","author":"QH Ding","year":"2013","unstructured":"Ding QH, et al. Celastrol, an inhibitor of heat shock protein 90beta potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase-2 in primary human osteoarthritic chondrocytes. Eur J Pharmacol. 2013;708(1\u20133):1\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1983_CR56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jphp.12835","volume":"70","author":"W Wang","year":"2018","unstructured":"Wang W, et al. Celastrol attenuates pain and cartilage damage via SDF-1\/CXCR4 signalling pathway in osteoarthritis rats. J Pharm Pharmacol. 2018;70(1):81\u20138.","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"1983_CR57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00011-020-01327-z","volume":"69","author":"K Feng","year":"2020","unstructured":"Feng K, et al. Chondro-protective effects of celastrol on osteoarthritis through autophagy activation and NF-\u03baB signaling pathway inhibition. Inflamm Res. 2020;69(4):385\u2013400.","journal-title":"Inflamm Res"},{"issue":"6","key":"1983_CR58","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jphp.13250","volume":"72","author":"DD Liu","year":"2020","unstructured":"Liu DD, et al. Celastrol ameliorates endoplasmic stress-mediated apoptosis of osteoarthritis via regulating ATF-6\/CHOP signalling pathway. J Pharm Pharmacol. 2020;72(6):826\u201335.","journal-title":"J Pharm Pharmacol"},{"key":"1983_CR59","doi-asserted-by":"crossref","first-page":"963506","DOI":"10.3389\/fphar.2022.963506","volume":"13","author":"G Yang","year":"2022","unstructured":"Yang G, et al. Celastrol ameliorates osteoarthritis via regulating TLR2\/NF-\u03baB signaling pathway. Front Pharmacol. 2022;13:963506.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1983_CR60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12951-020-00651-0","volume":"18","author":"T Jin","year":"2020","unstructured":"Jin T, et al. Intra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy against knee osteoarthritis. J Nanobiotechnol. 2020;18(1):94.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1983_CR61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69.","journal-title":"Nat Rev Dis Primers"},{"issue":"10287","key":"1983_CR62","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, et al. Gout. Lancet. 2021;397(10287):1843\u201355.","journal-title":"Gout Lancet"},{"issue":"10055","key":"1983_CR63","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth N, et al. Gout. Lancet. 2016;388(10055):2039\u201352.","journal-title":"Gout Lancet"},{"key":"1983_CR64","doi-asserted-by":"crossref","first-page":"153398","DOI":"10.1016\/j.phymed.2020.153398","volume":"80","author":"CY Yan","year":"2021","unstructured":"Yan CY, et al. Celastrol ameliorates propionibacterium acnes\/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3. Phytomedicine. 2021;80:153398.","journal-title":"Phytomedicine"},{"key":"1983_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940100391X","volume":"2001","author":"M Parkes","year":"2001","unstructured":"Parkes M, et al. Ulcerative colitis and Crohns disease: molecular genetics and clinical implications. Expert Rev Mol Med. 2001;2001:1\u201318.","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"1983_CR66","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbrc.2004.07.186","volume":"322","author":"GF Pinna","year":"2004","unstructured":"Pinna GF, et al. Celastrol inhibits pro-inflammatory cytokine secretion in Crohn\u2019s disease biopsies. Biochem Biophys Res Commun. 2004;322(3):778\u201386.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1983_CR67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.intimp.2015.03.033","volume":"26","author":"J Zhao","year":"2015","unstructured":"Zhao J, et al. Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy. Int Immunopharmacol. 2015;26(1):221\u20138.","journal-title":"Int Immunopharmacol"},{"key":"1983_CR68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbi.2013.12.007","volume":"210","author":"ME Shaker","year":"2014","unstructured":"Shaker ME, et al. Celastrol ameliorates murine colitis via modulating oxidative stress, inflammatory cytokines and intestinal homeostasis. Chem Biol Interact. 2014;210:26\u201333.","journal-title":"Chem Biol Interact"},{"issue":"2","key":"1983_CR69","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.intimp.2015.09.029","volume":"29","author":"Z Jia","year":"2015","unstructured":"Jia Z, et al. The natural compound celastrol inhibits necroptosis and alleviates ulcerative colitis in mice. Int Immunopharmacol. 2015;29(2):552\u20139.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1983_CR70","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1039\/C5MB00864F","volume":"12","author":"R Wang","year":"2016","unstructured":"Wang R, et al. A lipidomics investigation into the intervention of celastrol in experimental colitis. Mol Biosyst. 2016;12(5):1436\u201344.","journal-title":"Mol Biosyst"},{"issue":"2","key":"1983_CR71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.gpb.2022.05.002","volume":"20","author":"M Li","year":"2022","unstructured":"Li M, et al. Beneficial effects of celastrol on immune balance by modulating gut microbiota in experimental ulcerative colitis mice. Genomics Proteom Bioinf. 2022;20(2):288\u2013303.","journal-title":"Genomics Proteom Bioinf"},{"key":"1983_CR72","doi-asserted-by":"crossref","unstructured":"Xian J, et al. Colonic delivery of celastrol-loaded layer-by-layer liposomes with pectin\/trimethylated chitosan coating to enhance its anti-ulcerative colitis effects. Pharmaceutics. 2021;13(12).","DOI":"10.3390\/pharmaceutics13122005"},{"key":"1983_CR73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lfs.2018.05.020","volume":"205","author":"X Chen","year":"2018","unstructured":"Chen X, et al. Celastrol attenuates incision-induced inflammation and pain associated with inhibition of the NF-kappaB signalling pathway via SARM. Life Sci. 2018;205:136\u201344.","journal-title":"Life Sci"},{"key":"1983_CR74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2018.11.002","volume":"692","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Celastrol ameliorates inflammatory pain and modulates HMGB1\/NF-kappaB signaling pathway in dorsal root ganglion. Neurosci Lett. 2019;692:83\u20139.","journal-title":"Neurosci Lett"},{"issue":"1","key":"1983_CR75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11418-021-01564-4","volume":"76","author":"GJ Jin","year":"2022","unstructured":"Jin GJ, et al. Celastrol attenuates chronic constrictive injury-induced neuropathic pain and inhibits the TLR4\/NF-kappaB signaling pathway in the spinal cord. J Nat Med. 2022;76(1):268\u201375.","journal-title":"J Nat Med"},{"key":"1983_CR76","doi-asserted-by":"crossref","first-page":"213398","DOI":"10.1016\/j.bioadv.2023.213398","volume":"149","author":"H Zheng","year":"2023","unstructured":"Zheng H, et al. Celastrol-encapsulated microspheres prepared by microfluidic electrospray for alleviating inflammatory pain. Biomater Adv. 2023;149:213398.","journal-title":"Biomater Adv"},{"issue":"1","key":"1983_CR77","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12974-018-1124-6","volume":"15","author":"M Jiang","year":"2018","unstructured":"Jiang M, et al. Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33\/ST2 axis-mediated microglia\/macrophage M2 polarization. J Neuroinflammation. 2018;15(1):78.","journal-title":"J Neuroinflammation"},{"key":"1983_CR78","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fnins.2020.00847","volume":"14","author":"B Zhang","year":"2020","unstructured":"Zhang B, et al. Neuroprotective effects of celastrol on transient global cerebral ischemia rats via regulating HMGB1\/NF-kappaB signaling pathway. Front Neurosci. 2020;14:847.","journal-title":"Front Neurosci"},{"key":"1983_CR79","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.3390\/molecules26144124","volume":"26","author":"M Liu","year":"2021","unstructured":"Liu M, et al. Lipidomic profiling of ipsilateral brain and plasma after celastrol post-treatment in transient middle cerebral artery occlusion mice model. Molecules. 2021;26(14):4124.","journal-title":"Molecules"},{"issue":"1","key":"1983_CR80","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12974-021-02216-w","volume":"18","author":"DD Liu","year":"2021","unstructured":"Liu DD, et al. Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia-reperfusion. J Neuroinflammation. 2021;18(1):174.","journal-title":"J Neuroinflammation"},{"key":"1983_CR81","doi-asserted-by":"crossref","first-page":"p7420507","DOI":"10.1155\/2022\/7420507","volume":"2022","author":"M Chen","year":"2022","unstructured":"Chen M, et al. Celastrol protects against cerebral ischemia\/reperfusion injury in mice by inhibiting glycolysis through targeting HIF-1alpha\/PDK1 axis. Oxid Med Cell Longev. 2022;2022:p7420507.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1983_CR82","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpha.2022.12.002","volume":"13","author":"Z Hong","year":"2023","unstructured":"Hong Z, et al. Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke. J Pharm Anal. 2023;13(2):156\u201369.","journal-title":"J Pharm Anal"},{"key":"1983_CR83","doi-asserted-by":"crossref","first-page":"739707","DOI":"10.3389\/fcimb.2021.739707","volume":"11","author":"J Hou","year":"2021","unstructured":"Hou J, et al. The role of the microbiota in graves\u2019 disease and graves\u2019 orbitopathy. Front Cell Infect Microbiol. 2021;11:739707.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"1983_CR84","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.3892\/mmr.2016.5570","volume":"14","author":"H Li","year":"2016","unstructured":"Li H, et al. Celastrol inhibits IL-1beta-induced inflammation in orbital fibroblasts through the suppression of NF-kappaB activity. Mol Med Rep. 2016;14(3):2799\u2013806.","journal-title":"Mol Med Rep"},{"issue":"2","key":"1983_CR85","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/jop.2018.0092","volume":"35","author":"J Zhang","year":"2019","unstructured":"Zhang J, et al. Celastrol ameliorates inflammation in human retinal pigment epithelial cells by suppressing NF-kappaB signaling. J Ocul Pharmacol Ther. 2019;35(2):116\u201323.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1983_CR86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.intimp.2019.02.017","volume":"70","author":"Q Sun","year":"2019","unstructured":"Sun Q, et al. Celastrol ameliorates aspergillus fumigatus keratitis via inhibiting LOX-1. Int Immunopharmacol. 2019;70:101\u20139.","journal-title":"Int Immunopharmacol"},{"key":"1983_CR87","doi-asserted-by":"crossref","first-page":"p5574207","DOI":"10.1155\/2021\/5574207","volume":"2021","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, et al. Celastrol attenuates learning and memory deficits in an alzheimer\u2019s disease rat model. Biomed Res Int. 2021;2021:p5574207.","journal-title":"Biomed Res Int"},{"key":"1983_CR88","doi-asserted-by":"crossref","first-page":"102134","DOI":"10.1016\/j.redox.2021.102134","volume":"47","author":"C Zhang","year":"2021","unstructured":"Zhang C, et al. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson\u2019s disease. Redox Biol. 2021;47:102134.","journal-title":"Redox Biol"},{"key":"1983_CR89","doi-asserted-by":"crossref","first-page":"907993","DOI":"10.3389\/fimmu.2022.907993","volume":"13","author":"L Ng","year":"2022","unstructured":"Ng L, et al. Corrigendum: celastrol downmodulates alpha-synuclein-specific T cell responses by mediating antigen trafficking in dendritic cells. Front Immunol. 2022;13:907993.","journal-title":"Front Immunol"},{"issue":"1","key":"1983_CR90","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5483\/BMBRep.2017.50.1.114","volume":"50","author":"SY An","year":"2017","unstructured":"An SY, et al. Celastrol suppresses expression of adhesion molecules and chemokines by inhibiting JNK-STAT1\/NF-kappaB activation in poly(I:C)-stimulated astrocytes. BMB Rep. 2017;50(1):25\u201330.","journal-title":"BMB Rep"},{"key":"1983_CR91","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2014.09.001","volume":"742","author":"AA Abdin","year":"2014","unstructured":"Abdin AA, et al. Modulatory effect of celastrol on Th1\/Th2 cytokines profile, TLR2 and CD3+\u2009T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats. Eur J Pharmacol. 2014;742:102\u201312.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1983_CR92","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s11481-015-9598-9","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, et al. Celastrol ameliorates EAE induction by suppressing pathogenic T cell responses in the peripheral and central nervous systems. J Neuroimmune Pharmacol. 2015;10(3):506\u201316.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1983_CR93","first-page":"44","volume":"8","author":"H Yang","year":"2017","unstructured":"Yang H, et al. Celastrol attenuates multiple sclerosis and optic neuritis in an experimental autoimmune encephalomyelitis model. Front Pharmacol. 2017;8:44.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1983_CR94","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00011-019-01219-x","volume":"68","author":"SH Venkatesha","year":"2019","unstructured":"Venkatesha SH, et al. Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK\/SGK1-regulated mediators of autoimmune pathology. Inflamm Res. 2019;68(4):285\u201396.","journal-title":"Inflamm Res"},{"issue":"2","key":"1983_CR95","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.fct.2010.11.044","volume":"49","author":"HS Yang","year":"2011","unstructured":"Yang HS, et al. Celastrol isolated from tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells. Food Chem Toxicol. 2011;49(2):527\u201332.","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"1983_CR96","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cellsig.2012.12.005","volume":"25","author":"JH Kim","year":"2013","unstructured":"Kim JH, et al. Celastrol suppresses breast cancer MCF-7 cell viability via the AMP-activated protein kinase (AMPK)-induced p53-polo like kinase 2 (PLK-2) pathway. Cell Signal. 2013;25(4):805\u201313.","journal-title":"Cell Signal"},{"key":"1983_CR97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-4598-11-79","volume":"11","author":"L Ma","year":"2012","unstructured":"Ma L, et al. Epidermal growth factor (EGF) and interleukin (IL)-1beta synergistically promote ERK1\/2-mediated invasive breast ductal cancer cell migration and invasion. Mol Cancer. 2012;11:79.","journal-title":"Mol Cancer"},{"key":"1983_CR98","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519\u201350.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"1983_CR99","first-page":"644","volume":"22","author":"YY Yan","year":"2017","unstructured":"Yan YY, et al. Downregulation and subcellular distribution of HER2 involved in MDA-MB-453 breast cancer cell apoptosis induced by lapatinib\/celastrol combination. J BUON. 2017;22(3):644\u201351.","journal-title":"J BUON"},{"issue":"12","key":"1983_CR100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12032-022-01792-y","volume":"39","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cells. Med Oncol. 2022;39(12):189.","journal-title":"Med Oncol"},{"key":"1983_CR101","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cellsig.2017.01.009","volume":"31","author":"H Shrestha","year":"2017","unstructured":"Shrestha H, et al. Hakai, an E3-ligase for E-cadherin, stabilizes delta-catenin through src kinase. Cell Signal. 2017;31:135\u201345.","journal-title":"Cell Signal"},{"issue":"7","key":"1983_CR102","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3748\/wjg.v25.i7.808","volume":"25","author":"XB Wan","year":"2019","unstructured":"Wan XB, et al. Relationships among KRAS mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer. World J Gastroenterol. 2019;25(7):808\u201323.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1983_CR103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/10715760802585244","volume":"43","author":"Z Cao","year":"2009","unstructured":"Cao Z, et al. 35% oxygen pre-conditioning protects PC12 cells against death induced by hypoxia. Free Radic Res. 2009;43(1):58\u201367.","journal-title":"Free Radic Res"},{"issue":"32","key":"1983_CR104","doi-asserted-by":"crossref","first-page":"32790","DOI":"10.18632\/oncotarget.5411","volume":"6","author":"QW Jiang","year":"2015","unstructured":"Jiang QW, et al. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. Oncotarget. 2015;6(32):32790\u2013804.","journal-title":"Oncotarget"},{"key":"1983_CR105","first-page":"150","volume":"100\u2013101","author":"M Schulz","year":"2021","unstructured":"Schulz M, et al. Biglycan: a regulator of hepatorenal inflammation and autophagy. Matrix Biol. 2021;100\u2013101:150\u201361.","journal-title":"Matrix Biol"},{"key":"1983_CR106","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.3390\/ijms20225716","volume":"20","author":"D Guo","year":"2019","unstructured":"Guo D, et al. Celastrol induces necroptosis and ameliorates inflammation via targeting biglycan in human gastric carcinoma. Int J Mol Sci. 2019;20(22):5716.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"1983_CR107","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.7150\/thno.46728","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, et al. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells. Theranostics. 2020;10(22):10290\u2013308.","journal-title":"Theranostics"},{"issue":"5","key":"1983_CR108","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.tiv.2011.03.023","volume":"25","author":"H Mou","year":"2011","unstructured":"Mou H, et al. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas\/FasL-mediated pathways. Toxicol Vitro. 2011;25(5):1027\u201332.","journal-title":"Toxicol Vitro"},{"issue":"3","key":"1983_CR109","doi-asserted-by":"crossref","first-page":"e93151","DOI":"10.1371\/journal.pone.0093151","volume":"9","author":"KC Chiang","year":"2014","unstructured":"Chiang KC, et al. Celastrol blocks interleukin-6 gene expression via downregulation of NF-\u03baB in prostate carcinoma cells. PLoS ONE. 2014;9(3):e93151.","journal-title":"PLoS ONE"},{"issue":"6","key":"1983_CR110","first-page":"1129","volume":"40","author":"J Xu","year":"2015","unstructured":"Xu J, et al. Effect of celastrol in inhibiting metastasis of lung cancer cells by influencing akt signaling pathway and expressing integrins. Zhongguo Zhong Yao Za Zhi. 2015;40(6):1129\u201333.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"6","key":"1983_CR111","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.3892\/mmr.2016.5894","volume":"14","author":"H Zhang","year":"2016","unstructured":"Zhang H, et al. Effects of celastrol on enhancing apoptosis of ovarian cancer cells via the downregulation of microRNA\u201321 and the suppression of the PI3K\/Akt\u2013NF\u2013kappaB signaling pathway in an in vitro model of ovarian carcinoma. Mol Med Rep. 2016;14(6):5363\u20138.","journal-title":"Mol Med Rep"},{"issue":"4","key":"1983_CR112","first-page":"2260","volume":"40","author":"Y Chen","year":"2018","unstructured":"Chen Y, et al. Effect and mechanisms of celastrol on the apoptosis of HOS osteosarcoma cells. Oncol Rep. 2018;40(4):2260\u20138.","journal-title":"Oncol Rep"},{"issue":"8","key":"1983_CR113","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.18240\/ijo.2022.08.01","volume":"15","author":"Z Li","year":"2022","unstructured":"Li Z, et al. Celastrol inhibits laser-induced choroidal neovascularization by decreasing VEGF induced proliferation and migration. Int J Ophthalmol. 2022;15(8):1221\u201330.","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"1983_CR114","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s13277-014-2686-2","volume":"36","author":"Y Li","year":"2015","unstructured":"Li Y, et al. CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF. Tumour Biol. 2015;36(2):737\u201345.","journal-title":"Tumour Biol"},{"issue":"8","key":"1983_CR115","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1007\/s13277-015-3282-9","volume":"36","author":"H Akter","year":"2015","unstructured":"Akter H, et al. Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer. Tumour Biol. 2015;36(8):6053\u201362.","journal-title":"Tumour Biol"},{"key":"1983_CR116","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.2147\/OTT.S313933","volume":"14","author":"M Youns","year":"2021","unstructured":"Youns M, et al. Celastrol modulates multiple signaling pathways to inhibit proliferation of pancreatic cancer via DDIT3 and ATF3 up-regulation and RRM2 and MCM4 down-regulation. Onco Targets Ther. 2021;14:3849\u201360.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1983_CR117","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cbin.11952","volume":"47","author":"S Wang","year":"2023","unstructured":"Wang S, et al. Celastrol acts as a new histone deacetylase inhibitor to inhibit colorectal cancer cell growth via regulating macrophage polarity. Cell Biol Int. 2023;47(2):492\u2013501.","journal-title":"Cell Biol Int"},{"issue":"1","key":"1983_CR118","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/21691401.2020.1725025","volume":"48","author":"S Law","year":"2020","unstructured":"Law S, et al. Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models. Artif Cells Nanomed Biotechnol. 2020;48(1):542\u201359.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"1983_CR119","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/10717544.2017.1326540","volume":"24","author":"P Li","year":"2017","unstructured":"Li P, et al. Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2. Drug Deliv. 2017;24(1):834\u201345.","journal-title":"Drug Deliv"},{"issue":"1","key":"1983_CR120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/nu10010009","volume":"10","author":"C Mandato","year":"2017","unstructured":"Mandato C, et al. Nutrition and liver disease. Nutrients. 2017;10(1):9.","journal-title":"Nutrients"},{"key":"1983_CR121","volume-title":"World health statistics 2022: monitoring health for the SDGs, sustainable development goals","author":"O World Health","year":"2022","unstructured":"World Health O. World health statistics 2022: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization. 2022."},{"key":"1983_CR122","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2017.08.036","volume":"814","author":"W Xin","year":"2017","unstructured":"Xin W, et al. A new mechanism of inhibition of IL-1beta secretion by celastrol through the NLRP3 inflammasome pathway. Eur J Pharmacol. 2017;814:240\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1983_CR123","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmet.2016.11.002","volume":"6","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, et al. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. Mol Metab. 2017;6(1):138\u201347.","journal-title":"Mol Metab"},{"key":"1983_CR124","doi-asserted-by":"crossref","first-page":"857956","DOI":"10.3389\/fphar.2022.857956","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, et al. Celastrol: an update on itshepatoprotective properties and the linked molecular mechanisms. Front Pharmacol. 2022;13:857956.","journal-title":"Front Pharmacol"},{"key":"1983_CR125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2016.04.045","volume":"784","author":"W Chang","year":"2016","unstructured":"Chang W, et al. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms. Eur J Pharmacol. 2016;784:173\u201380.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1983_CR126","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/jcmm.14805","volume":"24","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. Celastrol exerts anti-inflammatory effect in liver fibrosis via activation of AMPK-SIRT3 signalling. J Cell Mol Med. 2020;24(1):941\u201353.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"1983_CR127","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","volume":"12","author":"P Luo","year":"2022","unstructured":"Luo P, et al. Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta Pharm Sin B. 2022;12(5):2300\u201314.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"1983_CR128","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10495-016-1294-6","volume":"21","author":"X Liu","year":"2016","unstructured":"Liu X, et al. The ROS derived mitochondrial respirstion not from NADPH oxidase plays key role in Celastrol against angiotensin II-mediated HepG2 cell proliferation. Apoptosis. 2016;21(11):1315\u201326.","journal-title":"Apoptosis"},{"issue":"4","key":"1983_CR129","first-page":"2053","volume":"42","author":"LP Han","year":"2018","unstructured":"Han LP, et al. Effect of celastrol on toll\u2013like receptor 4\u2013mediated inflammatory response in free fatty acid\u2013induced HepG2 cells. Int J Mol Med. 2018;42(4):2053\u201361.","journal-title":"Int J Mol Med"},{"issue":"4","key":"1983_CR130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","volume":"61","author":"S Mandard","year":"2004","unstructured":"Mandard S, et al. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci. 2004;61(4):393\u2013416.","journal-title":"Cell Mol Life Sci"},{"key":"1983_CR131","doi-asserted-by":"crossref","first-page":"114058","DOI":"10.1016\/j.bcp.2020.114058","volume":"178","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, et al. Celastrol ameliorates acute liver injury through modulation of PPARalpha. Biochem Pharmacol. 2020;178:114058.","journal-title":"Biochem Pharmacol"},{"key":"1983_CR132","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41401-023-01067-w","volume":"44","author":"SR Chen","year":"2023","unstructured":"Chen SR, et al. Celastrol attenuates hepatitis C virus translation and inflammatory response in mice by suppressing heat shock protein 90beta. Acta Pharmacol Sin. 2023;44(8):1637\u201348.","journal-title":"Acta Pharmacol Sin"},{"issue":"Suppl 1","key":"1983_CR133","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1016\/j.dsx.2017.03.006","volume":"11","author":"H Zand","year":"2017","unstructured":"Zand H, et al. Signaling pathways linking inflammation to insulin resistance. Diabetes Metab Syndr. 2017;11(Suppl 1):S307\u20139.","journal-title":"Diabetes Metab Syndr"},{"key":"1983_CR134","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","volume":"40","author":"A Roy","year":"2016","unstructured":"Roy A, et al. Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways. Int Immunopharmacol. 2016;40:79\u201389.","journal-title":"Int Immunopharmacol"},{"key":"1983_CR135","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1038\/ncomms13997","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, et al. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat Commun. 2017;8:13997.","journal-title":"Nat Commun"},{"issue":"10","key":"1983_CR136","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1002\/jcp.26547","volume":"233","author":"X Zhang","year":"2018","unstructured":"Zhang X, et al. Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA. J Cell Physiol. 2018;233(10):6814\u201324.","journal-title":"J Cell Physiol"},{"key":"1983_CR137","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopha.2017.07.021","volume":"93","author":"MH Abu Bakar","year":"2017","unstructured":"Abu Bakar MH, et al. Improvement of mitochondrial function by celastrol in palmitate-treated C2C12 myotubes via activation of PI3K-Akt signaling pathway. Biomed Pharmacother. 2017;93:903\u201312.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1983_CR138","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcjd.2018.07.002","volume":"43","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Celastrol reversespalmitic acid-induced insulin resistance in HepG2 cells via restoring the miR-223 and GLUT4 pathway. Can J Diabetes. 2019;43(3):165\u201372.","journal-title":"Can J Diabetes"},{"issue":"6","key":"1983_CR139","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.bbadis.2019.02.002","volume":"1865","author":"P Fang","year":"2019","unstructured":"Fang P, et al. Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1alpha\/GLUT4 axis-mediated glucose consumption. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1341\u201350.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"1983_CR140","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/ptr.6314","volume":"33","author":"M Zhang","year":"2019","unstructured":"Zhang M, et al. Celastrol attenuates renal injury in diabetic rats via MAPK\/NF-\u03baB pathway. Phytother Res. 2019;33(4):1191\u20138.","journal-title":"Phytother Res"},{"issue":"1","key":"1983_CR141","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12906-020-03050-y","volume":"20","author":"Y Nie","year":"2020","unstructured":"Nie Y, et al. Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K\/AKT pathway. BMC Complement Med Ther. 2020;20(1):321.","journal-title":"BMC Complement Med Ther"},{"key":"1983_CR142","first-page":"2641248","volume":"2016","author":"LP Han","year":"2016","unstructured":"Han LP, et al. Protective effects of celastrol on diabetic liver injury via TLR4\/MyD88\/NF-kappaB signaling pathway in type 2 diabetic rats. J Diabetes Res. 2016;2016:2641248.","journal-title":"J Diabetes Res"},{"issue":"11","key":"1983_CR143","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1002\/fsn3.1917","volume":"8","author":"J Sun","year":"2020","unstructured":"Sun J, et al. Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice. Food Sci Nutr. 2020;8(11):6207\u201316.","journal-title":"Food Sci Nutr"},{"issue":"1","key":"1983_CR144","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12938-021-00904-5","volume":"20","author":"J Fang","year":"2021","unstructured":"Fang J, et al. Celastrol inhibits the proliferation and angiogenesis of high glucose-induced human retinal endothelial cells. Biomed Eng Online. 2021;20(1):65.","journal-title":"Biomed Eng Online"},{"issue":"1","key":"1983_CR145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/1547691X.2017.1394933","volume":"14","author":"Y Wei","year":"2017","unstructured":"Wei Y, Wang Y. Celastrol attenuates impairments associated with lipopolysaccharide-induced acute respiratory distress syndrome (ARDS) in rats. J Immunotoxicol. 2017;14(1):228\u201334.","journal-title":"J Immunotoxicol"},{"issue":"5","key":"1983_CR146","first-page":"541","volume":"33","author":"Z He","year":"2021","unstructured":"He Z, et al. [Celastrol alleviates sepsis-induced acute lung injury in rats by inhibiting the toll-like receptor 4\/nuclear factor-kappab inflammatory pathway]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021;33(5):541\u20135.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"1\u20133","key":"1983_CR147","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2009.03.078","volume":"612","author":"DY Kim","year":"2009","unstructured":"Kim DY, et al. Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. Eur J Pharmacol. 2009;612(1\u20133):98\u2013105.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"1983_CR148","first-page":"9302","volume":"10","author":"R Ren","year":"2017","unstructured":"Ren R, et al. Celastrol attenuates ventilator induced lung injury in mouse through inhibition of MAPK pathway. Int J Clin Exp Pathol. 2017;10(9):9302\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"1983_CR149","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3389\/fphar.2018.01276","volume":"9","author":"K Shi","year":"2018","unstructured":"Shi K, et al. Celastrol alleviates chronic obstructive pulmonary disease by inhibiting cellular inflammation induced by cigarette smoke via the Ednrb\/Kng1 signaling pathway. Front Pharmacol. 2018;9:1276.","journal-title":"Front Pharmacol"},{"issue":"10","key":"1983_CR150","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.118.313816","volume":"123","author":"K Kobiyama","year":"2018","unstructured":"Kobiyama K, Ley K. Atherosclerosis. Circ Res. 2018;123(10):1118\u201320.","journal-title":"Circ Res"},{"issue":"6","key":"1983_CR151","doi-asserted-by":"crossref","first-page":"e65477","DOI":"10.1371\/journal.pone.0065477","volume":"8","author":"L Gu","year":"2013","unstructured":"Gu L, et al. Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress. PLoS ONE. 2013;8(6):e65477.","journal-title":"PLoS ONE"},{"issue":"3","key":"1983_CR152","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bbrc.2020.08.076","volume":"532","author":"Y Shi","year":"2020","unstructured":"Shi Y, et al. Celastrol suppresses lipid accumulation through LXRalpha\/ABCA1 signaling pathway and autophagy in vascular smooth muscle cells. Biochem Biophys Res Commun. 2020;532(3):466\u201374.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1983_CR153","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1039\/C8BM01224E","volume":"7","author":"SD Allen","year":"2019","unstructured":"Allen SD, et al. Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis. Biomater Sci. 2019;7(2):657\u201368.","journal-title":"Biomater Sci"},{"key":"1983_CR154","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biopha.2017.04.093","volume":"91","author":"J Chen","year":"2017","unstructured":"Chen J, et al. Celastrol reduces IL-1beta induced matrix catabolism, oxidative stress and inflammation in human nucleus pulposus cells and attenuates rat intervertebral disc degeneration in vivo. Biomed Pharmacother. 2017;91:208\u201319.","journal-title":"Biomed Pharmacother"},{"key":"1983_CR155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.intimp.2018.11.029","volume":"66","author":"W Dai","year":"2019","unstructured":"Dai W, et al. Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats. Int Immunopharmacol. 2019;66:215\u201323.","journal-title":"Int Immunopharmacol"},{"key":"1983_CR156","first-page":"73","volume":"12","author":"LI Ortiz-Lopez","year":"2022","unstructured":"Ortiz-Lopez LI, Choudhary V, Bollag WB. Updated perspectives on keratinocytes and psoriasis: keratinocytes are more than innocent bystanders. Psoriasis (Auckl). 2022;12:73\u201387.","journal-title":"Psoriasis (Auckl)"},{"key":"1983_CR157","doi-asserted-by":"crossref","first-page":"1111798","DOI":"10.3389\/fphar.2023.1111798","volume":"14","author":"X Yuan","year":"2023","unstructured":"Yuan X, et al. Celastrol inhibits store operated calcium entry and suppresses psoriasis. Front Pharmacol. 2023;14:1111798.","journal-title":"Front Pharmacol"},{"key":"1983_CR158","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.12659\/MSM.914060","volume":"25","author":"R Zhang","year":"2019","unstructured":"Zhang R, et al. Celastrol enhances the anti-liver cancer activity of sorafenib. Med Sci Monit. 2019;25:4068\u201375.","journal-title":"Med Sci Monit"},{"key":"1983_CR159","doi-asserted-by":"crossref","first-page":"107879","DOI":"10.1016\/j.intimp.2021.107879","volume":"98","author":"M Jing","year":"2021","unstructured":"Jing M, et al. Celastrol inhibits rheumatoid arthritis through the ROS-NF-\u03baB-NLRP3 inflammasome axis. Int Immunopharmacol. 2021;98:107879.","journal-title":"Int Immunopharmacol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-024-01983-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:53:56Z","timestamp":1767200036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-024-01983-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1983"],"URL":"https:\/\/doi.org\/10.1007\/s00011-024-01983-5","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"23"}}